---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-021648"
form_type: "8-K"
ticker: "INSM"
cik: "0001104506"
company_name: "INSMED Inc"
filed_at: "2026-05-15T20:01:27+00:00"
generated_at: "2026-05-15T20:04:55.495342+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Shareholders elect Anderson and Desjardins as Class II directors at annual meeting

## Summary
- Anderson received 153.7M for vs. 32.1M withheld; Desjardins 164.4M for vs. 21.4M withheld.
- Non-binding say-on-pay for 2025 NEO compensation approved: 162.1M for, 23.7M against, 74.4K abstain.
- Ratification of Ernst & Young as auditor for 2026: 190.4M for, 7.0M against, 45.3K abstain.

## SEC filing metadata
- accession: 0001140361-26-021648
- form_type: 8-K
- ticker: INSM
- cik: 0001104506
- company_name: INSMED Inc
- filed_at: 2026-05-15T20:01:27+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1104506/000114036126021648/0001140361-26-021648-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1104506/000114036126021648/ef20073378_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-021648
- JSON: https://secwatch.observer/filing/0001140361-26-021648.json
- Plain text: https://secwatch.observer/filing/0001140361-26-021648.txt

## Key facts
- Shareholder Votes
  INSMED Inc shareholders approved Advisory Vote on the 2025 Compensation of Named Executive Officers at the 2026-05-13 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2026-05-13
  source text: By the following vote, shareholders approved, on an advisory, non-binding basis, the 2025 compensation of our named executive officers, as disclosed in the Proxy Statement: For Against Abstentions Broker Non-Votes 162,133,728 23,657,325 74,398 11,564,082
  evidence_url: https://www.sec.gov/Archives/edgar/data/1104506/000114036126021648/0001140361-26-021648-index.htm
- Shareholder Votes
  INSMED Inc shareholders approved Election of Two Class II Directors at the 2026-05-13 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-05-13
  source text: By the following votes, shareholders elected Elizabeth McKee Anderson and Clarissa Desjardins, Ph.D., to serve as Class II directors until the Company’s 2029 Annual Meeting of Shareholders: For Withheld Broker Non-Votes Elizabeth McKee Anderson 153,734,471 32,130,980 11,564,082 Clarissa Desjardins, Ph.D. 164,437,828 21,427,623 11,564,082
  evidence_url: https://www.sec.gov/Archives/edgar/data/1104506/000114036126021648/0001140361-26-021648-index.htm
- Shareholder Votes
  INSMED Inc shareholders approved Ratification of the Appointment of an Independent Registered Public Accounting Firm at the 2026-05-13 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-05-13
  source text: By the following vote, shareholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026: For Against Abstentions 190,386,612 6,997,613 45,308
  evidence_url: https://www.sec.gov/Archives/edgar/data/1104506/000114036126021648/0001140361-26-021648-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.